Login / Signup
Harleen Kaur Walia
(Harleen Walia)
ORCID
Publication Activity (10 Years)
Years Active: 2021-2022
Publications (10 Years): 3
Top Topics
Early Onset
Atomic Force Microscopy
Lymph Node
Phase Ii
Top Venues
Future oncology (London, England)
Xenobiotica; the fate of foreign compounds in biological systems
Pharmacogenomics
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Harleen Kaur Walia
,
Parul Sharma
,
Navneet Singh
,
Siddharth Sharma
Predictive role of polymorphic variants of phase II drug metabolising enzyme in modulating toxicity in North Indian lung cancer patients undergoing chemotherapy.
Xenobiotica; the fate of foreign compounds in biological systems
52 (3) (2022)
Harleen Kaur Walia
,
Navneet Singh
,
Siddharth Sharma
Association of NAT-2 gene polymorphisms toward lung cancer susceptibility and prognosis in North Indian patients treated with platinum-based chemotherapy.
Pharmacogenomics
23 (2) (2021)
Harleen Kaur Walia
,
Navneet Singh
,
Siddharth Sharma
Genetic polymorphisms in the mEH gene in relation to tobacco smoking: role in lung cancer susceptibility and survival in north Indian patients with lung cancer undergoing platinum-based chemotherapy.
Future oncology (London, England)
17 (35) (2021)